# Wegovy maker Novo Nordisk said surging demand for its first weight loss pill has put it on track to beat trading forecasts.

*biotech · news · 2026-05-06 · The Irish Times*

## Key points

- Novo Nordisk's Wegovy pill launch saw over two million prescriptions since January in the US.
- The Wegovy pill generated €300 million in Q1 sales, surpassing analyst expectations.
- Novo Nordisk plans international Wegovy pill launches outside the US in the second half of 2026.
- Adjusted sales guidance for the year improved, with projected dips reduced from 13% to 12%.

**Companies:** Novo Nordisk, Eli Lilly
**Countries:** Denmark, United States

[Read the full story on The Irish Times](https://www.irishtimes.com/business/2026/05/06/us-launch-of-weight-loss-pills-boosts-wegovy-maker-novo-nordisk/)

---

Canonical: https://newsio.io/n/7786d2f8-9f40-49db-8393-c8bfe28b7ad7/wegovy-maker-novo-nordisk-said-surging-demand-for-its-first-weight-loss-pill-has
Summarized by Newsio from The Irish Times. https://newsio.io/how-it-works